The expanded capacity will allow the company to support infectious disease and therapeutic vaccine developers through the manufacture of raw materials, in vitro transcription, mRNA purification, and lipid nanoparticle formulation, it said.

Arranta Bio adds new manufacturing facility
Arranta Bio is adding a 130,000-sq-ft facility in Boxborough, MA, to complement its facilities in Watertown, MA, and Gainesville, FL, bringing its total...